pms-vigilance-minder

Generates PMS plans, PSUR templates, and vigilance reporting timelines for medical devices.

1|Updated Jul 13, 2026
One-click install
npx skills add https://github.com/HalseyYang/Skills-HY --skill pms-vigilance-minder-halseyyang
Or copy as Structured Prompt for Agent
Please help me install this Agent Skill.
Skill: pms-vigilance-minder
Source: https://github.com/HalseyYang/Skills-HY/tree/main/pms-vigilance-minder
Command: npx skills add https://github.com/HalseyYang/Skills-HY --skill pms-vigilance-minder-halseyyang

SYSTEM DOCUMENTATION & REQUIREMENTS

💡 This Skill includes references (resource) components.

What problem does it solve? Medical device manufacturers must maintain compliant post-market surveillance and vigilance systems across multiple jurisdictions (EU MDR, FDA, NMPA, PMDA), each with different reporting timelines, PSUR requirements, and FSCA procedures that are difficult to track and operationalize. ## Core Features & Use Cases - PMS Plan & PSUR Generation: Builds a 9-part PMS Plan framework (data sources, metrics, CAPA triggers, responsibilities) and PSUR templates aligned to device class under EU MDR Articles 83-86. - Global Vigilance Timelines: Provides reporting deadline matrices and decision trees for serious incidents, FSCA/FSN, and trend reports across EU, FDA, China NMPA, Japan PMDA, Health Canada, and TGA. - Cybersecurity & AI Monitoring: Covers vulnerability management SLAs by CVSS score, coordinated vulnerability disclosure, and EU AI Act post-market monitoring for high-risk AI medical devices. - Use Case: A Class IIb device manufacturer entering the EU market uses this Skill to generate a complete PMS Plan, a PSUR template, and a vigilance reporting workflow with correct 10/15-day timelines and EUDAMED registration steps. ## Quick Start Ask the assistant to generate a PMS plan and vigilance reporting timeline for your Class IIb medical device sold in the EU and US markets.

Frequently Asked Questions about pms-vigilance-minder

High-intent search queries and answers about installing and using this skill.

FAQPage Schema
How do I create a PMS plan for EU MDR compliance?

A PMS plan under EU MDR Article 84 must define data collection methods, analysis metrics, CAPA triggers, and responsibilities across at least 8 data sources including complaints, adverse events, and PMCF. This Skill generates the full 9-part plan structure aligned with MDCG 2020-7.

What are the vigilance reporting timelines for EU MDR vs FDA?

EU MDR Article 87 requires serious incident reports within 15 days, or 10 days for death or serious public health threats. FDA 21 CFR 803 requires MDR reports within 30 calendar days, or 5 working days for urgent public health risks. Timelines start from first awareness of the event.

When is a PSUR required versus a PMSR?

Class I devices need only a PMS Report kept on file, while Class IIa devices require a PSUR at least every 2 years and Class IIb/III devices require one annually. Class III and implantable PSURs are submitted to the notified body via EUDAMED under Article 86(2).

Does EUDAMED vigilance reporting become mandatory in 2026?

No. The first four EUDAMED modules (Actor, UDI/Device, Notified Bodies, Market Surveillance) become mandatory on 2026-05-28, but the vigilance module is expected around 2027 Q2 per Commission Decision (EU) 2025/2371. Serious incidents and FSCAs still require immediate EUDAMED registration.

How should cybersecurity vulnerabilities be handled post-market?

Vulnerabilities are triaged by CVSS score with defined SLAs: Critical (9.0-10.0) requires assessment within 24 hours and remediation within 30 days, while lower severities allow longer windows. Coordinated vulnerability disclosure follows a 90-day timeline.

What are the limitations of this vigilance planning approach?

The Skill does not replace the legal duties of the PRRC, and final determination of whether an event is serious rests with regulatory authorities. Clinical event judgments still require medical experts, and AI performance thresholds must be scientifically justified in the PCCP.